0.01Open0.01Pre Close0 Volume32 Open Interest1.00Strike Price0.00Turnover275.39%IV240.07%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.1188Delta0.8647Gamma29.79Leverage Ratio-0.0008Theta0.0000Rho3.54Eff Leverage0.0002Vega
bluebird bio Stock Discussion
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
No comment yet